Risk factors affecting the long-term results of renal retransplantation

Transplantation Proceedings

Volumn 31, Issue 7, 1999, Pages 2858-2859

  Ishikawa, N ^a   Tanabe, K ^a   Tokumoto, T ^a   Shimmura, H ^a   Yagisawa, T ^a   Nakajima, I ^a   Fuchinoue, S ^a   Agishi, T ^a   Toma, H ^a  

^a Tokyo Women's Medical University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HLA ANTIGEN; HLA DR ANTIGEN; LYMPHOCYTE ANTIBODY; MIZORIBINE; OKT 3;

ADOLESCENT; ADULT; ALLOGRAFT; CHILD; CONFERENCE PAPER; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HLA TYPING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032698328     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00591-6     Document Type: Conference Paper

References (11)

1. Tanabe K., Ishikawa N., Toma H., et al. Transplant Proc. 30:1998;1805.
2. Thorogood J., Houwelingen J.C., Persijn G.G., et al. Transplantation. 52:1991;831.
3. Delmonico F.L., Tolkoff-Rubin N., Auchincloss H., et al. Arch Surg. 129:1994;354.
4. Roberts C.S., Lafond J., Fitts C.T., et al. J Am Coll Surg. 178:1994;59.
5. Sumrani N., Delaney V., Hong J.H., et al. Transplantation. 53:1992;52.
6. Tejani A., Sullivan E.K. Transplantation. 62:1996;606.
7. Douzdjian V., Rice J.C., Carson R.W., et al. Clin Transplantation. 10:1996;203.
8. Najarian J.S., Migliori R.J., Simmons R.L., et al. Transplant Proc. 20:1988;249.
9. Hendriks G.F.J., Persijn G.G., van Rood J.J., et al. Transplant Proc. 19:1987;733.
10. Doran M., Coppage M., Ruth J., et al. Transplant Proc. 19:1987;1988.
11. Almond P.S., Matas A.J., Najarian J.S., et al. Transplantation. 52:1991;253.